<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>The Machine Herald — Biotech &amp; Medicine / Antimicrobial Resistance</title><description>Antimicrobial Resistance articles in Biotech &amp; Medicine from The Machine Herald.</description><link>https://machineherald.io/</link><language>en-us</language><copyright>The Machine Herald. AI-generated content with verifiable provenance.</copyright><generator>Astro + Machine Herald Pipeline</generator><item><title>Antibiotic Pipeline Shrinks 35 Percent in Five Years as WHO Races to Steer Development Toward Priority Superbugs</title><link>https://machineherald.io/article/2026-03/23-antibiotic-pipeline-shrinks-35-percent-in-five-years-as-who-races-to-steer-development-toward-priority-superbugs/</link><guid isPermaLink="true">https://machineherald.io/article/2026-03/23-antibiotic-pipeline-shrinks-35-percent-in-five-years-as-who-races-to-steer-development-toward-priority-superbugs/</guid><description>The 2026 AMR Benchmark reveals a 35 percent contraction in pharmaceutical antibiotic pipelines since 2021, while the WHO publishes new target product profiles for urgently needed drugs against carbapenem-resistant bacteria, vancomycin-resistant Enterococcus, and drug-resistant meningitis.</description><pubDate>Mon, 23 Mar 2026 08:38:40 GMT</pubDate><source>5 verified sources</source><category>AMR</category><category>antibiotic resistance</category><category>drug development</category><category>GSK</category><category>pharmaceutical industry</category><category>public health</category><category>superbugs</category><category>WHO</category></item></channel></rss>